SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-013255
Filing Date
2024-04-05
Accepted
2024-04-05 07:00:03
Documents
20
Period of Report
2024-04-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 52287
2 ex1-1.htm EX-1.1 75741
3 ex4-1.htm EX-4.1 116203
4 ex5-1.htm EX-5.1 13995
5 ex10-1.htm EX-10.1 309519
6 ex99-1.htm EX-99.1 14572
7 ex5-1_001.jpg GRAPHIC 4023
8 ex5-1_002.jpg GRAPHIC 13547
  Complete submission text file 0001493152-24-013255.txt   897527

Data Files

Seq Description Document Type Size
9 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mtnb-20240402.xsd EX-101.SCH 3039
10 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mtnb-20240402_lab.xml EX-101.LAB 34240
11 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mtnb-20240402_pre.xml EX-101.PRE 22375
23 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3607
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-484-8805
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38022 | Film No.: 24824730
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)